Equecabtagene Autoleucel Injection

equecabtagene autoleucel · Nanjing IASO Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Equecabtagene Autoleucel Injection, covering 2025-06-19 to 2025-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection